Literature DB >> 17665990

Regulatory mechanisms of microRNAs involvement in cancer.

Muller Fabbri1, Mircea Ivan, Amelia Cimmino, Massimo Negrini, George A Calin.   

Abstract

MicroRNAs (miRNAs) are 19-24 nucleotide noncoding RNAs that regulate the translation and degradation of target mRNAs and are extensively involved in human cancers. One unexpected conclusion of the profiling and functional studies in tumourigenesis is that some miRNAs behave in cancer cells in a dual mode, resembling the 'Dr Jekyll and Mr Hyde' story, which centers on a conception of humanity as dual in nature. The authors and others have found that onco-miRNAs and suppressor-miRNAs can represent two different looks of the same gene, behaving as oncogenes or tumour suppressors depending on tissue type and specific targets. In this review, the authors analyse the regulatory mechanisms of the main miRNA genes involved in human tumourigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17665990     DOI: 10.1517/14712598.7.7.1009

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  65 in total

1.  Evaluation of normalization methods in mammalian microRNA-Seq data.

Authors:  Lana Xia Garmire; Shankar Subramaniam
Journal:  RNA       Date:  2012-04-24       Impact factor: 4.942

2.  MicroRNAs as new players in the genomic galaxy and disease puzzles.

Authors:  Elisa Barbarotto; Paola Secchiero; Abhijit Dasgupta; Paolo Fortina; George A Calin; Terry Hyslop
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

3.  Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription.

Authors:  Xiaoqing Tang; Latha Muniappan; Guiliang Tang; Sabire Ozcan
Journal:  RNA       Date:  2008-12-18       Impact factor: 4.942

Review 4.  Potential relevance of microRNAs in inter-species epigenetic communication, and implications for disease pathogenesis.

Authors:  Pál Perge; Zoltán Nagy; Ábel Decmann; Ivan Igaz; Peter Igaz
Journal:  RNA Biol       Date:  2016-10-28       Impact factor: 4.652

Review 5.  miR deregulation in CLL.

Authors:  Veronica Balatti; Yuri Pekarky; Lara Rizzotto; Carlo M Croce
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 6.  Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors.

Authors:  Annika Schaefer; Carsten Stephan; Jonas Busch; George M Yousef; Klaus Jung
Journal:  Nat Rev Urol       Date:  2010-04-06       Impact factor: 14.432

7.  Prognostic value of microRNA-20b expression level in patients with prostate cancer.

Authors:  Rongkui Zhang; Fuwei Li; Yuchong Wang; Ming Yao; Changliang Chi
Journal:  Histol Histopathol       Date:  2020-04-14       Impact factor: 2.303

Review 8.  [MicroRNA in uro-oncology : New hope for the diagnosis and treatment of tumors?].

Authors:  A Schaefer; M Jung; G Kristiansen; M Lein; M Schrader; K Miller; A Erbersdobler; C Stephan; K Jung
Journal:  Urologe A       Date:  2009-08       Impact factor: 0.639

9.  Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication.

Authors:  Jasmine K Ahluwalia; Sohrab Zafar Khan; Kartik Soni; Pratima Rawat; Ankit Gupta; Manoj Hariharan; Vinod Scaria; Mukesh Lalwani; Beena Pillai; Debashis Mitra; Samir K Brahmachari
Journal:  Retrovirology       Date:  2008-12-23       Impact factor: 4.602

10.  Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).

Authors:  Katy Hanlon; Claudius E Rudin; Lorna W Harries
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.